阅读并同意隐私协议、MTA和使用条款后进行下一步!
forget password?
By logging in, you agree to our Privacy policy, MTA and Terms of Use.
forget password?
By logging in, you agree to our Privacy policy, MTA and Terms of Use.
关于
康码
Kangma-Healthcode,康码(上海)生物科技有限公司,成立于2015年。该公司拥有来自全球制药公司和研发机构的专业人员的高科技核心,以及经验丰富的管理团队。 Kangma发明了世界级的DNA到蛋白质(D2P)技术,该技术将彻底改变生物研究,医学应用和制药行业。
Kangma-Healthcode 是新一代生物技术,致力于开发革命性的无细胞蛋白合成技术,疾病诊断微芯片,人类健康评估产品,拥有世界一流的研发,生产,营销服务,服务的现代化高科技企业。康码的科学技术专注于全球范围内的迫切全球需求,开发在工业规模上进行高质量无细胞蛋白质生产的实用手段,开发新技术,推进预诊断,准确监测,改善疾病的治疗和全球人类的生活质量。通过内部研发的核心技术和外部合作(例如建立完整的产品线),康码公司将成为未来技术的前沿。我们希望公司开发的产品和服务将大大降低医疗成本,消除疾病,从而为所有人类带来重大利益。
Kangma - Healthcode is a new-generation biotech targeting to develop revolutionary protein cell-free synthesis technologies, disease diagnosis micro chip, human health assessment products, with world class R&D, production, marketing services, as one modern high-tech enterprise. Science and technology at Kangma focuses on the urgent global needs that have currently no practical means of high-quality protein cell-free manufacture, in industrial scale, and to develop new technologies, to advance the pre-diagnosis, accurate monitoring, to improve the quality of life of the global human being. Through the internal R&D core technology and external cooperation, such as the establishment of a comprehensive product line, Kangma is generating the frontline of future technology 20-years ahead. We hope that the product and services developed by the company will dramatically decrease the healthcare cost, eliminate diseases, so to bring significant benefits on all patients.
Kangma - Healthcode was founded in 2015. The company contains a high-tech core of professionals from global pharmaceutical companies and research and development institutions together with experienced management team. Kangma is the first to invent the world-class DNA-to-Protein (D2P) technology that will revolutionize bio research, medical application and pharmaceutical industry.
沪公网安备 31011502014489号
©2015-2024 Kangma-Healthcode. All Rights Reserved.